Acadian Asset Management
HOWL icon

Acadian Asset Management’s Werewolf Therapeutics HOWL Stock Holding History

Acadian Asset Management’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,285
Closed -$67K – 2034
2025
Q3 		$67K Sell
34,285
-26,992
-44% -$37K ﹤0.01% 1598
2025
Q2 		$66K Sell
61,277
-189,399
-76% -$195K ﹤0.01% 1452
2025
Q1 		$242K Buy
250,676
+8,412
+3% +$11K ﹤0.01% 1224
2024
Q4 		$358K Sell
242,264
-23,095
-9% -$47.1K ﹤0.01% 1152
2024
Q3 		$561K Buy
265,359
+53,063
+25% +$121K ﹤0.01% 1057
2024
Q2 		$516K Buy
212,296
+39,413
+23% +$189K ﹤0.01% 1190
2024
Q1 		$1.12M Buy
172,883
+94,212
+120% +$549K ﹤0.01% 811
2023
Q4 		$303K Hold
78,671
– – ﹤0.01% 1143
2023
Q3 		$167K Hold
78,671
– – ﹤0.01% 1226
2023
Q2 		$238K Hold
78,671
– – ﹤0.01% 1236
2023
Q1 		$203K Buy
78,671
+49,170
+167% +$147K ﹤0.01% 1253
2022
Q4 		$60K Buy
+29,501
New +$77.2K ﹤0.01% 1545

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management's HOWL Position: Q4 2025 in Review

Acadian Asset Management sold out of Werewolf Therapeutics (HOWL) in Q4 2025, closing a stake of 34,285 shares — an estimated $67K sold.

Acadian Asset Management first reported a position in HOWL in Q4 2022 and held it in 12 quarters. The position peaked at $1.12M in Q1 2024. 51 funds tracked by Wall St. Rank hold HOWL as of Q4 2025.

  • Acadian Asset Management reported no remaining Werewolf Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Acadian Asset Management sold 34,285 Werewolf Therapeutics shares in Q4 2025, an estimated $67K.
  • Acadian Asset Management first reported a position in Werewolf Therapeutics in Q4 2022 and held it in 12 quarters.
  • Acadian Asset Management's Werewolf Therapeutics position peaked at $1.12M in Q1 2024.
  • 51 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2025.

Based on Acadian Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.